Union Health Minister Harsh Vardhan on Wednesday launched the second phase of a Coal India CSR initiative to provide financial assistance for treatment of underprivileged thalassemic patients. Launched in 2017, the Thalassemia Bal Sewa Yojana is a hematopoietic stem cell transplantation (HSCT) programme that aims to provide a one-time cure opportunity for haemoglobinopathies like thalassaemia and sickle cell disease for patients who have a matched family donor. The CSR initiative was targeted to provide financial assistance to a total of 200 patients by providing a package cost not exceeding Rs 10 lakh per HSCT. Vardhan congratulated the doctors of SGPGI Lucknow, PGI Chandigarh, AIIMS Delhi, CMC Vellore, Tata Medical Centre in Kolkata and Rajeev Gandhi Cancer Institute, Delhi for the successful transplantation of 135 children without charging any physician fee, according to a Health Ministry statement. "Data on the prevalence of silent carriers for various haemoglobinopathies show
Minister Harsh Vardhan on Tuesday cautioned people to be more careful and take the necessary precautions against coronavirus ahead of the festive season
Vardhan had earlier said a Covid-19 vaccine is likely to be available by the first quarter of 2021
Emergency use of Covid-19 vaccines only after trial data
Warns of spike in cases during winter; China, UAE among the few countries have allowed such authorisation
On the issue of how the government plans to roll out the Covid-19 vaccine, he said that it is anticipated that supplies of vaccines would be available in limited quantities in the beginning
Terming such claims made in certain sections of the media as "fake news", Vardhan urged people to refrain from believing any unverified statements
Union Health Minister Dr Harsh Vardhan on Tuesday launched the Ayush Standard Treatment Protocol
Health minister has revealed country's vaccination plans for coronavirus. 200-250 million of India's population will get the vaccine by July 21
Human challenge trials, which have raised ethical concerns, involve exposing the participants to the virus on purpose to study the effectiveness of the vaccine
He also said that the government was also keeping an eye on immunity data with regard to Covid-19 while finalising these plans
Union Health Minister Harsh Vardhan clarified on Sunday that the government is yet to take a final decision on phase-3 trials of the Russian COVID-19 vaccine candidate Sputnik V.
The technologies were launched under a joint initiative of CSIR, Unnat Bharat Abhiyan (UBA), Indian Institute of Technology Delhi (IITD) and Vijnana Bharti (VIBHA)
Document calls for structural modification in workplaces, installation of physical barriers such as clear glass.
India is faring better than many developed nations in all parameters of Covid-19, Union Health Minister Harsh Vardhan said on Tuesday as he highlighted the "continuously rising" recovery rate
Jammu and Kashmir National Conference president Farooq Abdullah spoke to Union Health Minister Harsh Vardhan on Monday
Health Minister Harsh Vardhan said that the findings of the soon-to-be-released second sero survey indicated that India was still far from achieving any kind of herd immunity
Harsh Vardhan reiterated the the Narendra Modi government's commitment to increase the expenditure on public health to 2.5 per cent of India's gross domestic product (GDP) by 2025.
Warning against complacency, Vardhan said that the second sero survey findings make it necessary for everyone to follow Covid appropriate behavior.
Union Health Minister Dr Harsh Vardhan on Saturday said that over 5 lakh personal protective equipment per day are being produced by the 110 PPE manufacturers in the country."Now we have 110 PPE manufacturers in India, producing over 5 lakh per day. States who used to complain about not getting an adequate number of PPEs, now say they do not have a place to keep them when we talk about sending PPEs," Harsh Vardhan said here at the 79th Foundation Day of Council of Scientific and Industrial Research (CSIR).The Union Health Minister further said that India has conducted around 7 crore tests for COVID-19 and the recovery rate is improving."In the initial phase, the recovery rate stood at 9-12 per cent. But today, the recovery rate is around 82 per cent and the fatality rate is around 1.6 per cent," he said."We started with one lab when the COVID-19 crisis started but today we have 1823 labs. We have crossed 7 crore tests and are doing tests around 13-15 lakhs per day during the past few .